Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 58.10
-0.20 (-0.34%)
Aug 19, 2026, 1:30 PM CST
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 5 billion as of August 19, 2026. Its market cap has decreased by -15.51% in one year.
Market Cap
5.00B
Enterprise Value
5.16B
Revenue
2.11B
Ranking
n/a
PE Ratio
23.31
Stock Price
58.10
ChartMarket Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 5.00B, an increase of 835.27%. That is a compound annual growth rate of 10.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 5.00B | -7.46% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 6.61B |
| SCI Pharmtech | 6.38B |
| Formosa Laboratories | 6.28B |
| Orient Pharma | 5.36B |
| Orient EuroPharma | 4.20B |
| Tien Liang BioTech | 4.12B |
| LIWANLI Innovation | 4.05B |
| Easywell Biomedicals | 3.74B |